Hard to Treat Diseases (HTDS)

[2future4u]

Actually HTDS acts as a public vehicle for those private entities, to that end HTDS has no operations other than those coming from its subsidiries i.e the largest China vaccine distributor and a stem cell research team. Revenues coming from the latter might be a cash $$ derived from patents whereas Mellow Hope has about $15 Million coming from sales. Slavica Biochem is a good one because their work creates awareness coupled with volume and if they make a breakthrough in the field of MS research, this medical doctors research team could easily turn us into millionaires! Good point worth addressing is they use financing vehicle (HTDS) to finance their projects, buy equipment etc. On the other hand, non-believers are going for a physical proof Mellow Hope wins tenders all over the world yet sticking to the 'factual info' about preferred shares issue. I am of opinion that this temporarily skull'n'bones issue is being resolved as we speak and great thing on their part are audits being in the works so they could file them in Q4 2009. Great things to come in 2010.